Egypt's GASC buys 41,500 T soybean oil in local tender - traders
GASC was seeking cargoes of at least 3,000 tonnes of soyoil and 2,000 tonnes of sunflower oil for arrival March 25-April 15
Reuters News - 13 Feb 2020
Alexandria Co for Pharmaceuticals & Chemical Industries (AXPH.CA)
Also known as: Alex Co. Pharma, Alexandria Pharmaceuticals
144.00 EGP 2.781.969%
Alex Co. Pharma Stock Price & Performance
Recommendation
-
Div Yield
7.138%
P/E (Last 12 Month)
4.152
Upside
-
Target Price (Mean)
-
Open
142.50 EGP
Previous Close
141.22 EGP
Turnover
624.43K EGP
EPS
34.009 EGP
Volume
4,339
Transactions
29
Market Cap
706.10M EGP
IPO Date
27-Feb-1995
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Alexandria Co for Pharmaceuticals & Chemical Industries
Business Summary
Manufacture of generic drugs, dental cartridges, medicated adhesive tapes, plasters, surgical gloves and sterile gauze dressing,eye drops, vitamins and veterinary products.
Country of Incorporation
Ownership Type
Established In
1962
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| AXPH.CASE | Ordinary | EGP | Egypt SE | AXPH |
Contact details
Primary address
Alexandria Co for Pharmaceuticals & Chemical Industries BuildingGamila Abou Herid Road
Al Awayed Area
21511
Egypt
Alexandria
CONTACT
- Tel: +20 3-331-0224
- Tel: +20 3-331-2226
- Fax: +20 3-330-2221
- www.alexcopharma.net
Region
AlexandriaOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Abla Youssef Abdullah
Managing Director
Mr Mohammed Khalifa
Information Technology Director
Dr Mohammed Ashraf
Head of Marketing
Board Members
Dr Abla Youssef Abdullah
Chairperson and director representing Drug Holding Company
Dr Mohammed Hasan Suleiman Rabih
Director
Mr Saifuddine Ahmad Abdulmoati
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
Bahrain banks' asset quality to dwindle but remain contained for now: S&P
Majority of Saudi tenants planning to buy property within five years - report
Abu Dhabi's TAQA Group announces $294mln of private bonds issuance in Morocco
UAE's Emirates Islamic Bank confirms $500mln bond sale
UAE's e-commerce boom to drive gift card market to hit $2bln in 2024
Thursday Outlook: Stocks fall; Fed sees interest rates near zero till 2023
Oil steady; dollar rises; gold slips
Stock Market Data
Powered By Knowledge Direct